PAR Ann: Paradigm Doses First US Subjects under Phase 3 trial - 28th Apr 2022, 9:50am

[annb0t]

PAR Ann: Paradigm Doses First US Subjects under Phase 3 trial
Price Sensitive: Y
Date: 28th Apr 2022, 9:50am

>>> Read announcement: Google: PAR Market Announcements